Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Development of a Computable Phenotype for Hospital-Acquired Venous Thrombosis: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

Ryan M Thomas, MD, Insu Koh, PhD, Katherine Wilkinson, MS, Nicholas Roetker, PhD, Nicholas L Smith, PhD, Allen B Repp, MD, Chris E. Holmes, MD PhD, Timothy B Plante, MD MHS, Mary Cushman, MD, Neil A. Zakai, MDMSc

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-141047

Published: 2020

Journal Articles

Development and Validation of a Computable Phenotype for Bleeding in Hospitalized Patients: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study

Mansour Gergi, MD, Katherine Wilkinson, MS, Insu Koh, PhD, Jordan Munger, Nicholas L Smith, PhD, Nicholas Roetker, PhD, Mary Cushman, Allen B Repp, MD, Chris E. Holmes, MD PhD, Zakai A Neil, MD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-142407

Published: 2020

Journal Articles

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Andrew B Wilks, MD MS, Daniel Douce, MD, Steven Ades, MD, Mary Cushman, MD MSc, Neil A. Zakai, MD MSc, Chris E. Holmes, MD PhD

Blood (2019) 134 (Supplement_1): 709.

https://doi.org/10.1182/blood-2019-128831

Published: 2019

Journal Articles

Post Discharge Risk of Venous Thromboembolism in a Primary Care Population

Ximena Jordan Bruno, MD, Insu Koh, PhD, Pamela L Lutsey, PhD, Rob Walker, MPH, Nicholas Roetker, PhD, Nicholas L Smith, PhD, Timothy B Plante, MD MHS, Allen B Repp, MD, Chris E. Holmes, MD PhD, Mary Cushman, MD MSc, Neil A. Zakai, MD MSc

Blood (2019) 134 (Supplement_1): 934.

https://doi.org/10.1182/blood-2019-129203

Published: 2019

Journal Articles

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

Heather Wright, DO, Chris E. Holmes, MD PhD, Alissa Thomas, MD

Blood (2018) 132 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2018-99-120009

Published: 2018

Journal Articles

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Stacy E. Croteau, MD, Dunlei Cheng, PhD, Alice J. Cohen, MD, Chris E. Holmes, MD PhD, Peter A. Kouides, MD, Leslie J Raffini, MD MSCE, Michael Silvey, DO, Courtney Thornburg, MD, Allison P. Wheeler, MD, Ellis J Neufeld, MD PhD

Blood (2017) 130 (Supplement 1): 23.

https://doi.org/10.1182/blood.V130.Suppl_1.23.23

Published: 2017

Journal Articles

Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PACC): a Systems-Based, Personalized, Multidisciplinary Program to Increase Venous Thromboembolism (VTE) Risk Assessment, Education and Anticoagulant Prophylaxis in Cancer Outpatients Initiating Therapy

Steven Ades, MD, Susan Gilchrist, MD, Allison Holm, Karen Libby, RN, Mary Cushman, MD, Daniel Douce, MD, Chris E. Holmes, MD PhD

Blood (2017) 130 (Supplement 1): 217.

https://doi.org/10.1182/blood.V130.Suppl_1.217.217

Published: 2017

Journal Articles

Enhancing the Khorana Score: Traditional VTE Risk Factors Are Important in Predicting Long Term VTE Risk in Cancer Patients Initiating Chemotherapy

Daniel Douce, MD, Chris E. Holmes, MD PhD, Mary Cushman, MD, Charles Maclean, MD, Steven Ades, MD, Neil A Zakai, MDMSc

Blood (2017) 130 (Supplement 1): 753.

https://doi.org/10.1182/blood.V130.Suppl_1.753.753

Published: 2017

Journal Articles

Venous Thromboembolism (VTE) Increases the Healthcare Burden in Patients with Malignant Glioma (MG)

Heather Wright, DO, Daniel Douce, MD, Chris E. Holmes, MD PhD, Alissa Thomas, MD

Blood (2017) 130 (Supplement 1): 3364.

https://doi.org/10.1182/blood.V130.Suppl_1.3364.3364

Published: 2017

Journal Articles

Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis

Bhargavi Pulluri, MD, Benjamin Littenberg, MD, Inder Lal, MD, Chris E. HOlmes, MD PhD, Steven Ades, MD MSc

Blood (2016) 128 (22): 2598.

https://doi.org/10.1182/blood.V128.22.2598.2598

Published: 2016

Journal Articles

Activated Factors XI and IX and Tissue Factor in Patients with Advanced Cancer

Shannon M Prior, BS, Daniel Douce, MD, Steven Ades, MD MSc, Chris E. Holmes, MD PhD, Samuel Cory, BS, Mary Cushman, MD MSc, Peter Callas, PhD, Saulius Butenas, PhD

Blood (2016) 128 (22): 4947.

https://doi.org/10.1182/blood.V128.22.4947.4947

Published: 2016

Journal Articles

Effectiveness of a Short Course of Complex Lymphedema Therapy or Graduated Compression Stocking Therapy In the Treatment of Post-Thrombotic Syndrome (PTS): A Randomized Control Trial.

Chris E. Holmes, MD, PhD, Nadia M. Bambace, MD, FRCPC, Patricia Lewis, APRN, Peter Callas, Ph.D., Mary Cushman, MD, MSc

Blood (2010) 116 (21): 1087.

https://doi.org/10.1182/blood.V116.21.1087.1087

Published: 2010

NARROW

Development of a Computable Phenotype for Hospital-Acquired Venous Thrombosis: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

Development and Validation of a Computable Phenotype for Bleeding in Hospitalized Patients: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Post Discharge Risk of Venous Thromboembolism in a Primary Care Population

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PACC): a Systems-Based, Personalized, Multidisciplinary Program to Increase Venous Thromboembolism (VTE) Risk Assessment, Education and Anticoagulant Prophylaxis in Cancer Outpatients Initiating Therapy

Enhancing the Khorana Score: Traditional VTE Risk Factors Are Important in Predicting Long Term VTE Risk in Cancer Patients Initiating Chemotherapy

Venous Thromboembolism (VTE) Increases the Healthcare Burden in Patients with Malignant Glioma (MG)

Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis

Activated Factors XI and IX and Tissue Factor in Patients with Advanced Cancer

Effectiveness of a Short Course of Complex Lymphedema Therapy or Graduated Compression Stocking Therapy In the Treatment of Post-Thrombotic Syndrome (PTS): A Randomized Control Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only